Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment

Shaw Wei David Tsen, Nisha Donthi, Victor La, Wen Han Hsieh, Yen Der Li, Jayne Knoff, Alexander Chen, Tzyy Choou Wu, Chien Fu Hung, Samuel Achilefu, Kong-Thon Tsen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic inactivated vaccines is lacking. Conventional pathogen inactivation methods such as formalin, heat, ultraviolet light, and gamma rays cause structural alterations in vaccines that lead to reduced neutralizing antibody specificity, and in some cases, disastrous T helper type 2-mediated immune pathology. We have evaluated the potential of a visible ultrashort pulsed (USP) laser method to generate safe and immunogenic WIV vaccines without adjuvants. Specifically, we demonstrate that vaccination of mice with laser-inactivated H1N1 influenza virus at about a 10-fold lower dose than that required using conventional formalin-inactivated influenza vaccines results in protection against lethal H1N1 challenge in mice. The virus, inactivated by the USP laser irradiation, has been shown to retain its surface protein structure through hemagglutination assay. Unlike conventional inactivation methods, laser treatment did not generate carbonyl groups in protein, thereby reducing the risk of adverse vaccine-elicited T helper type 2 responses. Therefore, USP laser treatment is an attractive potential strategy to generate WIV vaccines with greater potency and safety than vaccines produced by current inactivation techniques

Original languageEnglish (US)
Article number051008
JournalJournal of Biomedical Optics
Volume20
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

ultrashort pulsed lasers
vaccines
influenza
Vaccines
Influenza Vaccines
viruses
Pulsed lasers
Viruses
deactivation
Pathogens
Formaldehyde
pathogens
mice
Inactivated Vaccines
Lasers
Pathology
Laser beam effects
proteins
Proteins
Neutralizing Antibodies

Keywords

  • influenza virus
  • pathogen inactivation
  • ultrashort pulsed lasers
  • whole inactivated virus vaccines

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Electronic, Optical and Magnetic Materials
  • Atomic and Molecular Physics, and Optics

Cite this

Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment. / Tsen, Shaw Wei David; Donthi, Nisha; La, Victor; Hsieh, Wen Han; Li, Yen Der; Knoff, Jayne; Chen, Alexander; Wu, Tzyy Choou; Hung, Chien Fu; Achilefu, Samuel; Tsen, Kong-Thon.

In: Journal of Biomedical Optics, Vol. 20, No. 5, 051008, 01.05.2015.

Research output: Contribution to journalArticle

Tsen, SWD, Donthi, N, La, V, Hsieh, WH, Li, YD, Knoff, J, Chen, A, Wu, TC, Hung, CF, Achilefu, S & Tsen, K-T 2015, 'Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment', Journal of Biomedical Optics, vol. 20, no. 5, 051008. https://doi.org/10.1117/1.JBO.20.5.051008
Tsen, Shaw Wei David ; Donthi, Nisha ; La, Victor ; Hsieh, Wen Han ; Li, Yen Der ; Knoff, Jayne ; Chen, Alexander ; Wu, Tzyy Choou ; Hung, Chien Fu ; Achilefu, Samuel ; Tsen, Kong-Thon. / Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment. In: Journal of Biomedical Optics. 2015 ; Vol. 20, No. 5.
@article{6b89aaf79b044c25920c8f752becd059,
title = "Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment",
abstract = "There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic inactivated vaccines is lacking. Conventional pathogen inactivation methods such as formalin, heat, ultraviolet light, and gamma rays cause structural alterations in vaccines that lead to reduced neutralizing antibody specificity, and in some cases, disastrous T helper type 2-mediated immune pathology. We have evaluated the potential of a visible ultrashort pulsed (USP) laser method to generate safe and immunogenic WIV vaccines without adjuvants. Specifically, we demonstrate that vaccination of mice with laser-inactivated H1N1 influenza virus at about a 10-fold lower dose than that required using conventional formalin-inactivated influenza vaccines results in protection against lethal H1N1 challenge in mice. The virus, inactivated by the USP laser irradiation, has been shown to retain its surface protein structure through hemagglutination assay. Unlike conventional inactivation methods, laser treatment did not generate carbonyl groups in protein, thereby reducing the risk of adverse vaccine-elicited T helper type 2 responses. Therefore, USP laser treatment is an attractive potential strategy to generate WIV vaccines with greater potency and safety than vaccines produced by current inactivation techniques",
keywords = "influenza virus, pathogen inactivation, ultrashort pulsed lasers, whole inactivated virus vaccines",
author = "Tsen, {Shaw Wei David} and Nisha Donthi and Victor La and Hsieh, {Wen Han} and Li, {Yen Der} and Jayne Knoff and Alexander Chen and Wu, {Tzyy Choou} and Hung, {Chien Fu} and Samuel Achilefu and Kong-Thon Tsen",
year = "2015",
month = "5",
day = "1",
doi = "10.1117/1.JBO.20.5.051008",
language = "English (US)",
volume = "20",
journal = "Journal of Biomedical Optics",
issn = "1083-3668",
publisher = "SPIE",
number = "5",

}

TY - JOUR

T1 - Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment

AU - Tsen, Shaw Wei David

AU - Donthi, Nisha

AU - La, Victor

AU - Hsieh, Wen Han

AU - Li, Yen Der

AU - Knoff, Jayne

AU - Chen, Alexander

AU - Wu, Tzyy Choou

AU - Hung, Chien Fu

AU - Achilefu, Samuel

AU - Tsen, Kong-Thon

PY - 2015/5/1

Y1 - 2015/5/1

N2 - There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic inactivated vaccines is lacking. Conventional pathogen inactivation methods such as formalin, heat, ultraviolet light, and gamma rays cause structural alterations in vaccines that lead to reduced neutralizing antibody specificity, and in some cases, disastrous T helper type 2-mediated immune pathology. We have evaluated the potential of a visible ultrashort pulsed (USP) laser method to generate safe and immunogenic WIV vaccines without adjuvants. Specifically, we demonstrate that vaccination of mice with laser-inactivated H1N1 influenza virus at about a 10-fold lower dose than that required using conventional formalin-inactivated influenza vaccines results in protection against lethal H1N1 challenge in mice. The virus, inactivated by the USP laser irradiation, has been shown to retain its surface protein structure through hemagglutination assay. Unlike conventional inactivation methods, laser treatment did not generate carbonyl groups in protein, thereby reducing the risk of adverse vaccine-elicited T helper type 2 responses. Therefore, USP laser treatment is an attractive potential strategy to generate WIV vaccines with greater potency and safety than vaccines produced by current inactivation techniques

AB - There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic inactivated vaccines is lacking. Conventional pathogen inactivation methods such as formalin, heat, ultraviolet light, and gamma rays cause structural alterations in vaccines that lead to reduced neutralizing antibody specificity, and in some cases, disastrous T helper type 2-mediated immune pathology. We have evaluated the potential of a visible ultrashort pulsed (USP) laser method to generate safe and immunogenic WIV vaccines without adjuvants. Specifically, we demonstrate that vaccination of mice with laser-inactivated H1N1 influenza virus at about a 10-fold lower dose than that required using conventional formalin-inactivated influenza vaccines results in protection against lethal H1N1 challenge in mice. The virus, inactivated by the USP laser irradiation, has been shown to retain its surface protein structure through hemagglutination assay. Unlike conventional inactivation methods, laser treatment did not generate carbonyl groups in protein, thereby reducing the risk of adverse vaccine-elicited T helper type 2 responses. Therefore, USP laser treatment is an attractive potential strategy to generate WIV vaccines with greater potency and safety than vaccines produced by current inactivation techniques

KW - influenza virus

KW - pathogen inactivation

KW - ultrashort pulsed lasers

KW - whole inactivated virus vaccines

UR - http://www.scopus.com/inward/record.url?scp=84920746858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920746858&partnerID=8YFLogxK

U2 - 10.1117/1.JBO.20.5.051008

DO - 10.1117/1.JBO.20.5.051008

M3 - Article

C2 - 25423046

AN - SCOPUS:84920746858

VL - 20

JO - Journal of Biomedical Optics

JF - Journal of Biomedical Optics

SN - 1083-3668

IS - 5

M1 - 051008

ER -